Lobular Neoplasia at Percutaneous Breast Biopsy: Variables Associated with Carcinoma at Surgical Excision
- 1 March 2008
- journal article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 190 (3), 637-641
- https://doi.org/10.2214/ajr.07.2768
Abstract
OBJECTIVE. The purpose of our study was to better define the rate and variables associated with cancer underestimation when lobular neoplasia is found at minimally invasive breast biopsy. MATERIALS AND METHODS. The records of 32,420 patients who underwent imaging-guided needle biopsy of the breast for mammographic or sonographic abnormalities from 1988 to 2000 were retrospectively reviewed. The 278 cases in which lobular neoplasia was the highest-risk lesion at biopsy were included. Of the 278 cases, 164 proceeded to surgical excision, allowing calculation of rates of underestimation from minimally invasive biopsy. RESULTS. Of the 32,420 minimally invasive breast biopsies, lobular neoplasia was found in 278 (0.9%). One hundred sixty-four of the 278 (59%) continued to surgical excision, where cancer was pathologically confirmed in 38 (23%). No difference was seen in the underestimation rates for lesions diagnosed as lobular carcinoma in situ (25%, 17 of 67 lesions) versus atypical lobular hyperplasia (22%, 21 of 97 lesions). Statistically significant underestimation of carcinoma was found with biopsy of masses (with or without associated microcalcifications) rather than calcifications only, a higher BI-RADS category (p < 0.0001), use of a core biopsy device rather than a vacuum device (p < 0.01), and obtaining fewer specimens (p < 0.0001). CONCLUSION. Significant sampling error occurs regardless of the type of core biopsy device, number of specimens obtained, histologic–radiographic concordance, mammographic appearance, and complete excision of the lesion as determined by imaging. For this reason, all patients with lobular neoplasia at core or vacuum-assisted biopsy should undergo surgical excision until further differentiating criteria can be determined.Keywords
This publication has 36 references indexed in Scilit:
- Bilateral Risk for Subsequent Breast Cancer After Lobular Carcinoma-In-Situ: Analysis of Surveillance, Epidemiology, and End Results DataJournal of Clinical Oncology, 2005
- Follow-up Surgical Excision Is Indicated When Breast Core Needle Biopsies Show Atypical Lobular Hyperplasia or Lobular Carcinoma In SituThe American Journal of Surgical Pathology, 2005
- Image-guided breast biopsy and management of high-risk lesionsRadiologic Clinics of North America, 2004
- Lobular neoplasia on core‐needle biopsy—Clinical significanceCancer, 2004
- Lobular Carcinoma In Situ Diagnosed By Core Needle Biopsy: When Should It Be Excised?Laboratory Investigation, 2003
- The Management of Lobular Neoplasia Identified on Percutaneous Core Breast BiopsyThe Breast Journal, 2003
- Lobular Neoplasia in Breast Core Needle Biopsy Specimens Is Not Associated With an Increased Risk of Ductal Carcinoma In Situ or Invasive CarcinomaAmerican Journal of Clinical Pathology, 2002
- Calcifications of Lobular Carcinoma In Situ of the BreastAmerican Journal of Roentgenology, 2001
- Lobular Carcinoma In situ on Core Biopsy—What is the Clinical Significance?Clinical Radiology, 2001
- Stereotactic core-needle biopsy of the breast: a report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American PathologistsCA: A Cancer Journal for Clinicians, 1997